Literature DB >> 9103517

Angiotensin II potentiates vasodilation of rat aorta by cAMP elevating agonists.

A Brizzolara-Gourdie1, J G Webb.   

Abstract

We previously observed an effect of the Ca++-mobilizing peptide, angiotensin II (ANG II), to potentiate agonist-stimulated adenosine 3',5'-cyclic monophosphate (cAMP) formation in rat cultured aortic smooth muscle cells. Consequently, it was postulated that the relaxant effects of dilator agents that act through cAMP formation would be enhanced in the presence of ANG II. To test this idea, we examined the influence of ANG II on agonist-induced relaxation of rat isolated aortic rings. Angiotensin II (0.1 microM) evoked a transient increase in the tone of KCI (30 mM)-precontracted aortae that returned to the original level of induced tension after about 20 min. Subsequent application of isoproterenol caused a concentration-dependent relaxation that was significantly greater in preparations pretreated with ANG II than in time-matched controls. Similarly, isoproterenol-induced relaxations of aortae precontracted with either phenylephrine (1 microM) or endothelin 1 (3 nM) were also augmented after ANG II treatment. The principal action of ANG II was to enhance the maximal relaxation evoked by isoproterenol without affecting the EC50 value, irrespective of the contractile agent used. This potentiating effect of ANG II was not specific for beta adrenoceptor-mediated relaxation because the relaxant response to iloprost, a prostaglandin I2 analog, was also increased after ANG II treatment. The effect of ANG II to enhance isoproterenol-induced relaxation was maintained in endothelium-denuded preparations. However, ANG II did not enhance the relaxation of vessels evoked through either the direct elevation of cAMP levels by dibutyryl cAMP or the stimulation of cyclic 3',5'-guanosine monophosphate formation by sodium nitroprusside. The data indicate that exposure of rat aortae to the constrictor peptide ANG II enhances the vasodilation of these blood vessels by agonists that stimulate cAMP formation. Such cross-talk between constrictor and dilator pathways could represent an important mechanism in the modulation of vascular tone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103517

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Palmitic acid methyl ester is a novel neuroprotective agent against cardiac arrest.

Authors:  Reggie Hui-Chao Lee; Alexandre Couto E Silva; HarLee E Possoit; Francesca M Lerner; Po-Yi Chen; Rinata Azizbayeva; Cristiane T Citadin; Celeste Yin-Chieh Wu; Jake T Neumann; Hung Wen Lin
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-11-23       Impact factor: 4.006

Review 2.  Endothelin in cardiovascular control: the role of endothelin antagonists.

Authors:  R R Wenzel; P Czyborra; T Lüscher; T Philipp
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

3.  Inhibition of angiotensin II Gq signaling augments beta-adrenergic receptor mediated effects in a renal artery stenosis model of high blood pressure.

Authors:  David M Harris; Xiongwen Chen; Stéphanie Pesant; Heather I Cohn; Scott M MacDonnell; Matthieu Boucher; Leif E Vinge; Philip Raake; Susan R Moraca; Dongjun Li; Patrick Most; Steven R Houser; Walter J Koch; Andrea D Eckhart
Journal:  J Mol Cell Cardiol       Date:  2008-09-30       Impact factor: 5.000

4.  Biochemical and molecular aspects of vascular adrenergic regulation of blood pressure in the elderly.

Authors:  William E Schutzer; Scott L Mader
Journal:  Int J Hypertens       Date:  2011-09-22       Impact factor: 2.420

5.  Angiotensin II, a unique vasoactive agent dissociates myosin light chain phosphorylation from contraction.

Authors:  Takashi Hirano; Takeharu Kaneda; Hiroshi Ozaki; Masatoshi Hori
Journal:  J Vet Med Sci       Date:  2017-12-20       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.